Page last updated: 2024-08-26

selenium and Infarction, Middle Cerebral Artery

selenium has been researched along with Infarction, Middle Cerebral Artery in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chen, F; Han, L; Pan, P; Shi, Y; Xie, L; Zhang, X1
Bartlett, PF; Hou, ST; Walker, TL; Wang, H; Zhang, S; Zhuo, Z1
Choi, YS; Jeong, JH; Kim, DM; Kim, YJ; Lee, KT; Ryu, JH; Yang, S1
Alborch, E; Burguete, MC; Marín, N; Pérez-Asensio, FJ; Pitarch, C; Romero, FJ; Salom, JB; Torregrosa, G1

Other Studies

4 other study(ies) available for selenium and Infarction, Middle Cerebral Artery

ArticleYear
Selenium Alleviates Cerebral Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial Fusion and Ferroptosis.
    Neurochemical research, 2022, Volume: 47, Issue:10

    Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Ferroptosis; Infarction, Middle Cerebral Artery; Iron; Mice; Mitochondrial Dynamics; Oxidative Stress; Reperfusion Injury; Selenium

2022
Selenium supplementation provides potent neuroprotection following cerebral ischemia in mice.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023, Volume: 43, Issue:7

    Topics: Animals; Brain Ischemia; Dietary Supplements; Dysbiosis; Infarction, Middle Cerebral Artery; Mice; Neuroprotection; Neuroprotective Agents; Reperfusion Injury; Selenium; Stroke

2023
Synthesis and Evaluation of Neuroprotective Selenoflavanones.
    International journal of molecular sciences, 2015, Dec-10, Volume: 16, Issue:12

    Topics: Animals; Antioxidants; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Flavanones; Humans; Infarction, Middle Cerebral Artery; Male; Mice, Inbred ICR; Neuroprotective Agents; Organometallic Compounds; Oxidative Stress; Selenium

2015
Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.
    European journal of pharmacology, 2004, Jul-08, Volume: 495, Issue:1

    Topics: Administration, Oral; Animals; Azoles; Body Weight; Brain; Brain Chemistry; Brain Ischemia; Drug Administration Schedule; Drug Evaluation, Preclinical; Glutathione; Infarction, Middle Cerebral Artery; Isoindoles; Male; Organoselenium Compounds; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion; Selenium; Spain; Time Factors

2004